Drug pricing regulator National Pharmaceutical Pricing Authority (NPPA) has received over ₹672 crore as fine till date from pharmaceutical firms for overcharging. Since inception, NPPA has issued 1,527 demand notices to companies for overcharging on sales of formulations at prices above the notified ceiling price. NPPA has recovered ₹294 crore during the current financial year till February.